MR-guided focused ultrasound (MRgFUS) has proven its efficacy and safety for the treatment of essential tremor (ET) and/or Parkinson's disease (PD). However, having a cardiac pacemaker has been considered an exclusion criterion for the use of MRgFUS. Only 2 patients with a cardiac pacemaker treated with MRgFUS have been previously reported, both treated using 1.5-T MRI. In this paper, the authors present their experience performing 3-T MRgFUS thalamotomy in 4 patients with an implanted cardiac pacemaker. Treatments were uneventful regarding complications or severe side effects. MRgFUS using 3-T MRI was found to be an efficient and safe treatment for ET and/or PD in patients with an MRI-compatible pacemaker.

Download full-text PDF

Source
http://dx.doi.org/10.3171/2024.6.FOCUS24171DOI Listing

Publication Analysis

Top Keywords

cardiac pacemaker
16
mr-guided focused
8
focused ultrasound
8
patients cardiac
8
pacemaker
5
mrgfus
5
3-t mr-guided
4
ultrasound thalamotomy
4
thalamotomy tremor
4
patients
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!